ChemoCentryx Securities Litigation
Homyk v. ChemoCentryx, Inc. et al.
United States District Court for the Northern District of California
Case No. 4:21-cv-03343-JST
Homyk v. ChemoCentryx, Inc. et al.
United States District Court for the Northern District of California
Case No. 4:21-cv-03343-JST
Welcome to the ChemoCentryx Securities Litigation Website
The information contained on this website is only a summary of the information presented in more detail in the Notice of Pendency of Class Action. Because this website is just a summary, you should review the Notice for additional details.
If you purchased or otherwise acquired the common stock of ChemoCentryx, Inc. from November 26, 2019, through May 6, 2021, inclusive, and were damaged thereby, this class action lawsuit may affect your rights.
The purpose of this website is to inform potential Class Members: (1) of a class action lawsuit that is now pending in the United States District Court Northern District of California (the “Court”) referred to Homyk v. ChemoCentryx, Inc., Master File No. 4:21-cv-03343-JST (the “Action”); and (2) that the Action has been certified by the Court to proceed as a class action on behalf of the Class, as defined below. There is no settlement and you are not being asked to submit a claim.
The Amended Consolidated Class Action Complaint alleges, among other things, that Defendants made misstatements and omissions to investors about the safety and efficacy of ChemoCentryx’s proprietary vasculitis drug called avacopan (now TAVNEOS®), and the Company’s application for FDA approval of avacopan; that these misstatements and omissions caused the price of ChemoCentryx common stock to be artificially inflated during the Class Period and caused damages to investors when the market later allegedly learned the truth allegedly concealed by Defendants’ misleading statements.
The Court-certified Class consists of persons and entities who purchased or otherwise acquired the common stock of ChemoCentryx, Inc. from November 26, 2019 through May 6, 2021, inclusive, and were damaged thereby. Certain persons are excluded from the Class by definition as discussed in ¶ 4 of the Notice, or may request exclusion from the Class as discussed in ¶ 7 of the Notice.
If you are a member of the Class, you may be entitled to participate in any benefits that may eventually be obtained for the Class as a result of this lawsuit. There is, however, no assurance that a judgment in favor of the Class will be granted. Please read the Notice to fully understand your rights and options.
|
Your Legal Rights and Options |
|
|
DO NOTHING |
Stay in this lawsuit. Await the outcome and share in any recovery
that may be achieved. Give up certain rights. By doing nothing, you keep the possibility of sharing in any recovery
that may result from a trial or a settlement. But if you give up any
rights you may have to sue Defendants separately about the issues and claims
being raised in this lawsuit, and you will be bound by the outcome of this
case. |
|
ASK TO BE EXCLUDED
BY JANUARY 14, 2025 |
Get out of this lawsuit. Get no recovery from it. Keep your
rights. If you ask to be excluded from this lawsuit, you will not be bound by
what the Court does in this case and will keep any right you might have to
sue Defendants separately about the same issues and claims being raised in
this lawsuit. If a recovery is later awarded in this case, you would
not share in that recovery. |
